Juli 2011 - IOZK

Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).

2011-07-31/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-07-31 / J Clin Oncol 29: 2011 (suppl 7; abstr 176)

Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1

2011-07-23/in Dendritic Cells, HIV/AIDS, International Publications /von 2011-07-23 / Vaccine 2011 Sep;29(38):6454-63

Treatment of high-grade glioma in children and adolescents

2011-07-22/in Dendritic Cells, Glioblastoma, International Publications /von 2011-07-22 / Neuro-oncology 2011 Oct;13(10):1049-58

Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies

2011-07-20/in International Publications, Micronutrients /von 2011-07-20 / Br J Haematol 2011 Aug;154(4):448-56

Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients

2011-07-19/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-07-19 / Clin. Cancer Res. 2011 Sep;17(17):5725-35

Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer

2011-07-01/in Dendritic Cells, International Publications, Ovarian Cancer /von 2011-07-01 / Immunotherapy 2011 Jul;3(7):805-7